David Langsam

Author Profile

Stories by David Langsam

Health & Biotech

Fliers, flameouts and fakers: what happened in biotechland in 2018

December 21, 2018November 1, 2021 | David Langsam

You've come a long way baby ... ASX biotech revenue is up 40 per cent over seven years. Picture: Getty

Health & Biotech

Biotechs report $11.7bn revenue and $1.9bn profit

September 5, 2017January 21, 2021 | David Langsam

Eureka ... Which biotech returned 394 per cent over ten years? Pic: Getty

Health & Biotech

Biotechs up 80pc over ten years, easily beating the ASX200

August 14, 2017February 9, 2019 | David Langsam